相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Time Trends and Treatment Pathways in Prescribing Individual Oral Anticoagulants in Patients with Nonvalvular Atrial Fibrillation: An Observational Study of More than Three Million Patients from Europe and the United States
Pareen Vora et al.
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE (2022)
Clinical outcomes of nonvitamin K oral anticoagulants and acenocoumarol for stroke prevention in contemporary practice: A population-based propensity-weighted cohort study
Clara L. Rodriguez-Bernal et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2021)
2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS)
Gerhard Hindricks et al.
EUROPEAN HEART JOURNAL (2021)
Existing Data Sources for Clinical Epidemiology: The PHARMO Database Network
Josephina G. Kuiper et al.
CLINICAL EPIDEMIOLOGY (2020)
Rationale and design of a European epidemiological post-authorization safety study (PASS) program: rivaroxaban use in routine clinical practice
Luis Alberto Garcia-Rodriguez et al.
EXPERT OPINION ON DRUG SAFETY (2020)
Comparing stroke prevention therapy of direct oral anticoagulants and vitamin K antagonists in patients with atrial fibrillation: a nationwide retrospective observational study
Lena M. Paschke et al.
BMC MEDICINE (2020)
Different Risk Profiles of European Patients Using Direct Oral Anticoagulants or Vitamin K Antagonists: a Rapid Review
Katrin Krueger et al.
CURRENT EPIDEMIOLOGY REPORTS (2020)
Incidence of direct oral anticoagulant use in patients with nonvalvular atrial fibrillation and characteristics of users in 6 European countries (2008-2015): A cross-national drug utilization study
Luisa Ibanez et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2019)
Estimated Effectiveness and Safety of Nonvitamin K Antagonist Oral Anticoagulants Compared With Optimally Acenocoumarol Anticoagulated Real-World in Patients With Atrial Fibrillation
Maria Asuncion Esteve-Pastor et al.
AMERICAN JOURNAL OF CARDIOLOGY (2018)
Effectiveness and Safety of Non-Vitamin K Oral Anticoagulants in Comparison to Phenprocoumon: Data from 61,000 Patients with Atrial Fibrillation
Stefan H. Hohnloser et al.
THROMBOSIS AND HAEMOSTASIS (2018)
Trends in initiation of direct oral anticoagulant therapies for atrial fibrillation in a national population-based cross-sectional study in the French health insurance databases
Laetitia Huiart et al.
BMJ OPEN (2018)
Evolving antithrombotic treatment patterns for patients with newly diagnosed atrial fibrillation
A. John Camm et al.
HEART (2017)
Efficacy and safety of non-vitamin K antagonist oral anticoagulants compared with warfarin in patients with atrial fibrillation
Leif Friberg et al.
OPEN HEART (2017)
Trends in the prescription of novel oral anticoagulants in UK primary care
Simone Y. Loo et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2017)
Use of Oral Anticoagulants for Stroke Prevention in Patients With Atrial Fibrillation Who Have a History of Intracranial Hemorrhage
Tze-Fan Chao et al.
CIRCULATION (2016)
2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS
Paulus Kirchhof et al.
EUROPEAN HEART JOURNAL (2016)
Factors Associated With Major Bleeding Events
Shaun G. Goodman et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2014)
Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials
Christian T. Ruff et al.
LANCET (2014)
Corticosteroids and risk of gastrointestinal bleeding: a systematic review and meta-analysis
Sigrid Narum et al.
BMJ OPEN (2014)
2012 focused update of the ESC Guidelines for the management of atrial fibrillation
A. John Camm et al.
EUROPEAN HEART JOURNAL (2012)
分享论文
